TITLE:

EFPIA welcomes the publication by the European Observatory of a new report appraising the economic impact of counterfeiting and piracy in the pharmaceutical sector

BRIEF:

According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), the report entitled “The economic cost of IPR infringement in the pharmaceutical industry” underscores the serious public health threat posed by counterfeit medicines.